Quantcast
In Directing Stem Cells Study Shows Context Matters

In Directing Stem Cells, Study Shows Context Matters

Terry Devitt, University of Wisconsin-Madison Figuring out how blank slate stem cells decide which kind of cell they want to be when they grow up — a muscle cell, a bone cell, a neuron — has been no small task for science. Human...

Latest cloning Stories

2014-09-15 23:11:09

Global Stem Cells Group has announced an exclusive representative contract with Chilean health management, development and biotechnology company Consortia Innovas, SA. MIAMI (PRWEB) September 15, 2014 Global Stem Cells Group, Inc. has signed an exclusive representative contract with Consortia Innovas, SA, a Santiago, Chile-based health management, development and biotech company. Founded by entrepreneur Enrique Testart, M.D., Consortia Innovas focuses on helping patients gain access to...

2014-09-10 16:26:28

SAN BRUNO, Calif., Sept. 10, 2014 /PRNewswire/ -- September is designated as National Childhood Cancer Awareness Month. The federal health observance provides an opportunity to heighten awareness of the formidable public health challenges presented by childhood cancer. According to the National Cancer Institute, cancer is the leading cause of death by disease in children and adolescents ages 1 to 19 years old in the United States. Pediatric patients with blood cancers have diseased...

2014-09-05 23:01:05

A study published in STEM CELLS on August 30, 2014, details a new, simple, and highly efficient way to convert cells taken from an adult’s skin into stem cells that have the potential to differentiate into white blood cells. Durham, NC (PRWEB) September 05, 2014 A study published in STEM CELLS on August 30, 2014, details a new, simple, and highly efficient way to convert cells taken from an adult’s skin into stem cells that have the potential to differentiate into white blood cells....

2014-09-05 08:23:18

HONG KONG, Sept. 5, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company's Compensation Committee (the "Committee") has approved an allocation of 5,840,000 restricted share units ("RSUs") to be issued to selected members (the "Potential Participants") of the CCBC management team....

2014-08-29 23:10:02

For more than a week, Boston’s Adult Stem Cell Technology Center, LLC has been declining offers from participants in the Amyotrophic Lateral Sclerosis (ALS) Ice Bucket Challenge who wish to make donations for research that does not use human embryonic stem cells or tissues derived from aborted fetuses. The company has informed those wishing to donate that its for-profit status prevents it from inviting or receiving charitable donations. Boston, MA (PRWEB) August 29, 2014 Due to a...

2014-08-29 08:24:07

DALLAS, August 29, 2014 /PRNewswire/ -- Launched June 2014, the "Stem Cell Research Products - Opportunities, Tools, and Technologies" market intelligence report supplies research supply companies with the real-time data necessary to make effective product development decisions, sell effectively to scientists, and take market share from the competition. Full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell...

2014-08-25 08:27:08

HONG KONG, Aug. 25, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has been informed that Magnum Opus International Holdings Limited ("Magnum"), a private vehicle that is controlled by CCBC Chairman Mr. Yuen KAM and involves the CCBC management team, together with Cordlife...

2014-08-25 08:27:03

- Wednesday, August 27, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT - MENLO PARK, Calif., Aug. 25, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a leading biotechnology company in the emerging field of regenerative medicine, announced today that it will host an investor briefing conference call and slide presentation via webcast on Wednesday, August 27, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT. At this briefing, Asterias management will review the Company's business...

2014-08-22 23:05:15

In a new study published in STEM CELLS Translational Medicine on July 14, 2014, researchers from Tokyo Medical and Dental University along with a team from Osaka University may have found a potentially powerful approach for creating human induced pluripotent stem cells (hiPSCs) for clinical use. Durham, NC (PRWEB) August 22, 2014 Human induced pluripotent stem cells (hiPSCs) have great potential in the field of regenerative medicine because they can be coaxed to turn into specific cells;...

2014-08-22 12:25:53

DUBLIN, Aug. 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The global molecular biology enzymes market was valued at $2,847.63 million in 2013, and is expected to grow at a CAGR of 13.74% to reach $5,420.63 million in 2018. Molecular...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related